Luxeptinib (CG-806) is a novel pan-FLT3/pan-BTK inhibitor that is administered orally. It exhibits potent and reversible inhibition of these enzymes, acting through a non-covalent mechanism. Luxeptinib effectively induces cell cycle arrest, apoptosis, or
Molecular Weight:
495.43
CAS Number:
[1616428-23-9]
Formula:
C25H17F4N5O2
* VAT and and shipping costs not included. Errors and price changes excepted
